Good Tyler, Cila Jorida, Mosher Rhiannon, Puka Klajdi, Reynolds Shaghig, Catt Barbara, Mounchili Aboubakar, Gravel-Tropper Denise, Quail Patrick, McGeer Allison, Moser Andrea, Ashcroft Madeleine, Daley Peter, Piggott Katrina, Leis Jerome, Morrissey Mark
Data, Surveillance and Foresight Branch, Public Health Agency of Canada, Ottawa, ON.
Impact & Innovation Unit, Privy Council Office, Ottawa, ON.
Can Commun Dis Rep. 2025 Jan 2;51(1):43-53. doi: 10.14745/ccdr.v51i01a06. eCollection 2025 Jan.
Antimicrobial resistance (AMR) is associated with significant human and financial costs, particularly among vulnerable populations like older adults living in long-term care homes (LTCHs). Urinary tract infection (UTI) is the leading indication for antibiotic use in this population, with some estimates suggesting that up to 70% of these prescriptions may be avoidable.
The purpose of this study is to develop and test novel behavioural science-informed antimicrobial stewardship (AMS) quality improvement strategies in Canadian LTCHs, which aim to decrease unnecessary testing and treatment for residents who lack the minimum clinical signs and symptoms of UTI.
The quality improvement strategy is a two-pronged approach that includes 1) targeted education for essential care providers (family and friends of LTCH residents) about UTI and benefits of AMS, which strives to outline a positive role for this group in UTI management, and 2) monthly feedback to LTCH staff on their facility's urine culture ordering rates.
The protocol was piloted in a single LTCH; a process evaluation of the pilot implementation served to refine the research protocol, which is being implemented in eight LTCHs across Canada using an eight-month stepped wedge randomized cluster design.
This protocol represents a behavioural science-informed intervention to improve AMS across LTCHs. If successful, this model of care could be scalable across Canadian LTCHs, offering an inclusive approach that aims to empower clinicians, non-regulated healthcare staff, residents and their family and friends to improve health outcomes as antibiotic stewards.
抗菌药物耐药性(AMR)会带来巨大的人力和经济成本,在长期护理机构(LTCH)中的老年人等弱势群体中尤为如此。尿路感染(UTI)是该人群使用抗生素的主要指征,一些估计表明,这些处方中高达70%可能是不必要的。
本研究的目的是在加拿大的长期护理机构中开发并测试基于行为科学的新型抗菌药物管理(AMS)质量改进策略,旨在减少对缺乏尿路感染最低临床体征和症状的居民进行不必要的检测和治疗。
质量改进策略采用双管齐下的方法,包括:1)针对基本护理提供者(长期护理机构居民的家人和朋友)开展关于尿路感染及抗菌药物管理益处的针对性教育,努力勾勒出该群体在尿路感染管理中的积极作用;2)每月向长期护理机构工作人员反馈其所在机构的尿培养送检率。
该方案在一个长期护理机构进行了试点;对试点实施情况的过程评估有助于完善研究方案,目前该方案正在加拿大的八个长期护理机构中采用为期八个月的阶梯式楔形随机整群设计实施。
本方案代表了一种基于行为科学的干预措施,以改善各长期护理机构的抗菌药物管理。如果成功,这种护理模式可在加拿大各长期护理机构推广,提供一种包容性方法,旨在使临床医生、非正规医护人员、居民及其家人和朋友作为抗菌药物管理者增强能力,从而改善健康结局。